Swiss National Bank
OPTR

Swiss National Bank’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Swiss National Bank’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-46,200
Closed -$582K – 2563
2013
Q3 		$582K Hold
46,200
– – ﹤0.01% 1836
2013
Q2 		$669K Buy
+46,200
New +$673K ﹤0.01% 1708

Swiss National Bank's OPTR Position: Q4 2013 in Review

Swiss National Bank sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 46,200 shares — an estimated $582K sold.

Swiss National Bank first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $669K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Swiss National Bank reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Swiss National Bank sold 46,200 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $582K.
  • Swiss National Bank first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Swiss National Bank's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $669K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Swiss National Bank's 13F filing for Q4 2013, filed 31 Jan 2014.